solvay_live243_p02a04 somEdito

Dossier
104917
34
DANCE (DICETEL ® AND NUTRITION
COMBINATION EVENT)
WHEN THE DIETICIAN
SUPPORTS THE FAMILY
PHYSICIAN
SolvayInnovationTrophy2006
The treatment of patients suffering from
irritable bowel syndrome (IBS) is often
a source of frustration for the family
physician. Because of the very nature
of the problem, patients are reluctant to discuss
their physical or psychological problems
and the chances of being able to control the
symptoms over a long period are limited.
In practice, the patients return to consult their
doctor because they find that the effects
of the Dicetel ® treatment are incomplete or too
slow. Many get impatient, do not assiduously
follow the prescriptions and interrupt the
treatment. The idea is to combine treatment
with Dicetel ® with an appropriate diet,
defined by qualified nutritionists.
Dicetel ® is now prescribed for three months and
at the same time the patients receive a voucher
for a visit to the dietician, reimbursed
by Solvay Pharmaceuticals. This system, which
was set up in 2005, had a positive outcome
with an increase in sales of Dicetel ®
and an improvement in relations between
the physicians and the patients.
> Carolyn Bush.
> PHARMACEUTICALS SECTOR
103564
TOWARDS SAFER MEDICAL
AND BIOLOGICAL PACKAGING
PLASTICS AT THE SERVICE
OF MEDICINE
Adetailed study on the content
of leachable compounds in the plastics
materials has been carried out in order to:
• reinforce their acceptance and therefore
strengthen our market position;
• look into the possibility of their use in cell
culture, a new growing market.
A comprehensive analysis strategy has been
developed, taking into account not only the
characteristics of the containers and contents
but also all the possible crossed
contaminations. This approach combines,
on the one hand, available analytical
techniques, some of which are being used up
to their detection limits, and, on the other it
nurtures a permanent dialogue with internal
clients, in all the study phases.
This methodology may be widely extended,
mainly to the plastic materials used in
medical and food applications.
> Serge Eeckhoudt; Lodewick Berkenbosch;
Wim Devos; Patrizia Dorazio; Robert Elcik;
Peter Karsten; Ingrid Luyten; Jean Morel;
Pascal Pennetreau; Juan Villanueva.
> CC ANALYTICAL TECHNOLOGIES
101364
THE BUY SOLVAY PROJECT LEVERAGE EXISTING
GROUP NETWORKS TO GROW THE BUSINESS
BUY SOLVAY!
The Group is changing from one day to the
next, making it difficult for the mere mortals
at Solvay to keep track of its entire products
portfolio.
This issue applies not only to the Group’s
employees, but also to its clients and suppliers.
And in view of the cost of acquiring
a new client, it quickly becomes clear that
reinforcing existing commercial contacts
is a better promise of new sales.
To do so, the International Purchasing Department
(DIA) has set up a project that exploits our
existing networks by putting the focus on product
knowledge and communication.
This campaign targets:
• the Group’s employees, as they are in touch
with certain prescribers of our products,
physicians for example;
• the Solvay buyers, whether they need to order
products for construction (for example, PVDF
for the chemical reactors in Rosignano/Italy)
or for production (for example sodium silicate
to manufacture percarbonate on the same site);
• the buyers of our clients and of our suppliers,
in order to consolidate our privileged links
(for example Pipelife tubes installed
by Gaz de France).
This initiative is unprecedented in the industry. It
was launched in 2003 for a four year period. And
the results generated are already very promising
(EUR 7, 5 million per year today with an estimated
potential of EUR 18 million per year).
> Jean-François Dehem; Patrick Balletto;
Michel Bokobza; Oscar Corti; Chantal De Brabanter;
Patrick Lacroix; Jean-Pierre Meriaux; Freddy Smit.
> CC DIA